REGENXBIO (RGNX)
(Delayed Data from NSDQ)
$16.04 USD
+0.14 (0.88%)
Updated Apr 24, 2024 04:00 PM ET
After-Market: $16.05 +0.01 (0.06%) 6:54 PM ET
3-Hold of 5 3
F Value D Growth B Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/01/2024
Time: -- |
3/2024 | $-1.28 | 0.00% |
Earnings Summary
For their last quarter, REGENXBIO (RGNX) reported earnings of -$1.43 per share, missing the Zacks Consensus Estimate of -$1.27 per share. This reflects a negative earnings surprise of 12.60%. Look out for RGNX's next earnings release expected on May 01, 2024. For the next earning release, we expect the company to report earnings of -$1.28 per share, reflecting a year-over-year increase of 16.34%.
Earnings History
Price & Consensus
Zacks News for RGNX
Regenxbio (RGNX) Reports Q4 Loss, Lags Revenue Estimates
RGNX: What are Zacks experts saying now?
Zacks Private Portfolio Services